A Time Series Analysis of Trends in Medicare Utilization and Reimbursement for Cancer Immunotherapy Drugs: 2012-2017
View ORCID ProfilePranav Puri, Denis Cortese, Sujith Baliga
doi: https://doi.org/10.1101/2020.06.27.20141721
Pranav Puri
1Mayo Clinic Alix School of Medicine, Scottsdale, Arizona
BADenis Cortese
2Healthcare Delivery and Policy Program, Arizona State University, Scottsdale, Arizona
MDSujith Baliga
3Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio
MDData Availability
Data available on request
Posted June 30, 2020.
A Time Series Analysis of Trends in Medicare Utilization and Reimbursement for Cancer Immunotherapy Drugs: 2012-2017
Pranav Puri, Denis Cortese, Sujith Baliga
medRxiv 2020.06.27.20141721; doi: https://doi.org/10.1101/2020.06.27.20141721
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (163)
- Cardiovascular Medicine (2361)
- Dermatology (206)
- Emergency Medicine (378)
- Epidemiology (11749)
- Forensic Medicine (10)
- Gastroenterology (700)
- Genetic and Genomic Medicine (3716)
- Geriatric Medicine (348)
- Health Economics (632)
- Health Informatics (2386)
- Health Policy (929)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3480)
- Nursing (197)
- Nutrition (522)
- Oncology (1815)
- Ophthalmology (535)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1029)
- Primary Care Research (418)
- Public and Global Health (6124)
- Radiology and Imaging (1270)
- Respiratory Medicine (825)
- Rheumatology (379)
- Sports Medicine (321)
- Surgery (399)
- Toxicology (50)
- Transplantation (171)
- Urology (145)